Journal for ImmunoTherapy of Cancer : Impact Factor & More
eISSN: 2051-1426pISSN: 2051-1426
Open AccessShare this on:
Key Metrics
CiteScore 
14.3
Eigenfactor
0.01 - 0.05
Impact Factor
10 - 15
Scite Index
0.90 5-Year SI
SJR
Q1Oncology
SNIP
2.23
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Journal for ImmunoTherapy of Cancer
Journal for ImmunoTherapy of Cancer Journal Specifications
Indexed in the following public directories
Web of Science 
DOAJ 
SJR
| Overview | |
| Publisher | BMJ PUBLISHING GROUP |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2885 |
| Publication Time | 18 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | Society for Immunotherapy of Cancer |
| Frequency | Continuous publication |
| Publication Start Year | 2013 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY-NC, CC BY, CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in Journal for ImmunoTherapy of Cancer ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Journal for ImmunoTherapy of Cancer
Pan-cancer analysis in the real-world setting uncovers immunogenomic drivers of acquired resistance post-immunotherapy.
- 19 May 2026
- Journal for immunotherapy of cancer
Clinical outcomes and spatial transcriptomic profiles of CD19/20 CAR-T therapy in relapsed or refractory B-cell non-Hodgkin\u2019s lymphoma
- 17 May 2026
- Journal for Immunotherapy of Cancer
Phase I trial of CJRB-101 plus pembrolizumab in patients with metastatic non-small cell lung cancer, head and neck squamous cell carcinoma and melanoma
- 16 May 2026
- Journal for Immunotherapy of Cancer
Targeting CD74 may mitigate immune-escape features and enhance BCMA CAR-T activity in preclinical models of relapsed/refractory multiple myeloma
- 14 May 2026
- Journal for Immunotherapy of Cancer
Morning versus afternoon administration of immune checkpoint inhibitors in metastatic non-small-cell lung cancer
- 14 May 2026
- Journal for Immunotherapy of Cancer
Feeder-free generation of functional dendritic cells from human pluripotent stem cells
- 13 May 2026
- Journal for Immunotherapy of Cancer
Pan-cancer analysis in the real-world setting uncovers immunogenomic drivers of acquired resistance post-immunotherapy.
- 19 May 2026
- Journal for immunotherapy of cancer
Clinical outcomes and spatial transcriptomic profiles of CD19/20 CAR-T therapy in relapsed or refractory B-cell non-Hodgkin\u2019s lymphoma
- 17 May 2026
- Journal for Immunotherapy of Cancer
Phase I trial of CJRB-101 plus pembrolizumab in patients with metastatic non-small cell lung cancer, head and neck squamous cell carcinoma and melanoma
- 16 May 2026
- Journal for Immunotherapy of Cancer
Targeting CD74 may mitigate immune-escape features and enhance BCMA CAR-T activity in preclinical models of relapsed/refractory multiple myeloma
- 14 May 2026
- Journal for Immunotherapy of Cancer
Morning versus afternoon administration of immune checkpoint inhibitors in metastatic non-small-cell lung cancer
- 14 May 2026
- Journal for Immunotherapy of Cancer
Feeder-free generation of functional dendritic cells from human pluripotent stem cells
- 13 May 2026
- Journal for Immunotherapy of Cancer
FAQs on Journal for ImmunoTherapy of Cancer
How long has Journal for ImmunoTherapy of Cancer been actively publishing? 
What is the publishing frequency of Journal for ImmunoTherapy of Cancer?
How many articles did Journal for ImmunoTherapy of Cancer publish last year?
What is the eISSN & pISSN for Journal for ImmunoTherapy of Cancer?
What is Citescore for Journal for ImmunoTherapy of Cancer?
What is SNIP score for Journal for ImmunoTherapy of Cancer?
What is the SJR for Journal for ImmunoTherapy of Cancer?
Who is the publisher of Journal for ImmunoTherapy of Cancer?
